UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Toll-like receptor 10 is down-regulated in serum of patients with relapsing–remitting multiple sclerosis but not associated with Epstein-Barr virus

Journal of neurovirology, 2023-04, Vol.29 (2), p.203-210

2023

Volltextzugriff (PDF)

Association between interleukin-4 and interleukin-10 single nucleotide polymorphisms and multiple sclerosis among Iraqi patients

Neurological sciences, 2019-11, Vol.40 (11), p.2383-2389

2019

Volltextzugriff (PDF)

Interleukin‐39 is a novel cytokine associated with type 2 diabetes mellitus and positively correlated with body mass index

Endocrinology, diabetes & metabolism, 2023-05, Vol.6 (3), p.e409-n/a

2023

Volltextzugriff (PDF)

Evaluation of human β‑defensins in the cerebrospinal fluid of suspected meningitis

Biomedical reports, 2023-01, Vol.18 (1), p.10-10, Article 10

2023

Volltextzugriff (PDF)

Molecular landscape of the interleukin-40 encoding gene, C17orf99, in patients with acute myeloid leukemia

Gene, 2024-04, Vol.904, p.148214-148214, Article 148214

2024

Volltextzugriff (PDF)

Multi-objectives TLBO hybrid method to select the related risk features with rheumatism disease

Neural computing & applications, 2021-08, Vol.33 (15), p.9025-9034

2021

Volltextzugriff (PDF)

Soluble HLA-G is upregulated in serum of patients with severe COVID-19

Human immunology, 2021-10, Vol.82 (10), p.726-732

2021

Volltextzugriff (PDF)

Interleukin-37 gene expression is down-regulated in patients with acute myeloid leukemia and shown to be affected by CD14 and HLA-DR immunophenotypes

Cytokine (Philadelphia, Pa.), 2023-11, Vol.171, p.156368-156368, Article 156368

2023

Volltextzugriff (PDF)

Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19)

Cytokine (Philadelphia, Pa.), 2021-12, Vol.148, p.155702-155702, Article 155702

2021

Volltextzugriff (PDF)

Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk

Immunology letters, 2023-02, Vol.254, p.1-5

2023

Volltextzugriff (PDF)

Corrigendum to “A novel signature of interleukins 36α, 37, 38, 39 and 40 in ankylosing spondylitis” [Cytokine 162 (2023) 156117]

Cytokine (Philadelphia, Pa.), 2023-06, Vol.166, p.156195-156195, Article 156195

2023

Volltextzugriff (PDF)

Corrigendum to “Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk” [Immunology Letters 254 (2023) 1–5]

Immunology letters, 2023-11, Vol.263, p.135-137

2023

Volltextzugriff (PDF)

A novel signature of interleukins 36α, 37, 38, 39 and 40 in ankylosing spondylitis

Cytokine (Philadelphia, Pa.), 2023-02, Vol.162, p.156117-156117, Article 156117

2023

Volltextzugriff (PDF)

A novel intergenic variant, rs2004339 A/G, of the gene encoding interleukin-40, C17orf99, is associated with risk of rheumatoid arthritis in Iraqi women

Molecular immunology, 2023-12, Vol.164, p.39-46

2023

Volltextzugriff (PDF)

HLA-G 14-bp insertion/deletion polymorphism and risk of coronavirus disease 2019 (COVID-19) among Iraqi patients

Human immunology, 2022-06, Vol.83 (6), p.521-527

2022

Volltextzugriff (PDF)

Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection

Immunology letters, 2023-08, Vol.260, p.24-34

2023

Volltextzugriff (PDF)

Human beta-defensins 2 and 4 are dysregulated in patients with coronavirus disease 19

Microbial pathogenesis, 2021-11, Vol.160, p.105205-105205, Article 105205

2021

Volltextzugriff (PDF)

Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech)

Human immunology, 2023-02, Vol.84 (2), p.71-74

2023

Volltextzugriff (PDF)

Significance of the chemokine CXCL10 and human beta-defensin-3 as biomarkers of pulmonary tuberculosis

Tuberculosis (Edinburgh, Scotland), 2021-05, Vol.128, p.102078-102078, Article 102078

2021

Volltextzugriff (PDF)

Evaluation of interleukins (IL-1α, IL-1Ra, IL-12, IL-17A, IL-31, and IL-33) and chemokines (CXCL10 and CXCL16) in the serum of male patients with ankylosing spondylitis

International immunopharmacology, 2024-03, Vol.129, p.111697-111697, Article 111697

2024

Volltextzugriff (PDF)

The 5’ untranslated region variant rs3811050 C/T of the interleukin-38 encoding gene is associated with susceptibility to rheumatoid arthritis in Iraqi women

Molecular biology reports, 2024-12, Vol.51 (1), p.589-589, Article 589

2024

Volltextzugriff (PDF)

Interleukin-38 promoter variants and risk of COVID-19 among Iraqis

Immunobiology (1979), 2022-11, Vol.227 (6), p.152301-152301, Article 152301

2022

Volltextzugriff (PDF)

Serum interleukin-41 concentrations are decreased in women with rheumatoid arthritis and are not affected by menopausal status, disease activity, or medication

Revista Colombiana de Reumatologia, 2024-02

2024

Volltextzugriff (PDF)

Relapsing-remitting multiple sclerosis: A profile of interleukine-1 gene cluster polymorphisms in Iraqi patients

Journal of neuroimmunology, 2020-09, Vol.346, p.577291-577291, Article 577291

2020

Volltextzugriff (PDF)

Genetic variants in IL4RA, IL6, and IL12B genes and susceptibility to hepatitis B and C virus infections among Iraqi patients

Journal of medical virology, 2020-12, Vol.92 (12), p.3448-3458

2020

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(112)
Tagungsberichte
(2)

Sprache

Englisch
(114)
Arabisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Toll-like receptor 10 is down-regulated in serum of patients with relapsing–remitting multiple sclerosis but not associated with Epstein-Barr virus

Association between interleukin-4 and interleukin-10 single nucleotide polymorphisms and multiple sclerosis among Iraqi patients

Interleukin‐39 is a novel cytokine associated with type 2 diabetes mellitus and positively correlated with body mass index

Evaluation of human β‑defensins in the cerebrospinal fluid of suspected meningitis

Molecular landscape of the interleukin-40 encoding gene, C17orf99, in patients with acute myeloid leukemia

Multi-objectives TLBO hybrid method to select the related risk features with rheumatism disease

Soluble HLA-G is upregulated in serum of patients with severe COVID-19

Interleukin-37 gene expression is down-regulated in patients with acute myeloid leukemia and shown to be affected by CD14 and HLA-DR immunophenotypes

Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19)

Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk

Corrigendum to “A novel signature of interleukins 36α, 37, 38, 39 and 40 in ankylosing spondylitis” [Cytokine 162 (2023) 156117]

Corrigendum to “Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk” [Immunology Letters 254 (2023) 1–5]

A novel signature of interleukins 36α, 37, 38, 39 and 40 in ankylosing spondylitis

A novel intergenic variant, rs2004339 A/G, of the gene encoding interleukin-40, C17orf99, is associated with risk of rheumatoid arthritis in Iraqi women

HLA-G 14-bp insertion/deletion polymorphism and risk of coronavirus disease 2019 (COVID-19) among Iraqi patients

Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection

Human beta-defensins 2 and 4 are dysregulated in patients with coronavirus disease 19

Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech)

Significance of the chemokine CXCL10 and human beta-defensin-3 as biomarkers of pulmonary tuberculosis

Evaluation of interleukins (IL-1α, IL-1Ra, IL-12, IL-17A, IL-31, and IL-33) and chemokines (CXCL10 and CXCL16) in the serum of male patients with ankylosing spondylitis

The 5’ untranslated region variant rs3811050 C/T of the interleukin-38 encoding gene is associated with susceptibility to rheumatoid arthritis in Iraqi women

Interleukin-38 promoter variants and risk of COVID-19 among Iraqis

Serum interleukin-41 concentrations are decreased in women with rheumatoid arthritis and are not affected by menopausal status, disease activity, or medication

Relapsing-remitting multiple sclerosis: A profile of interleukine-1 gene cluster polymorphisms in Iraqi patients

Genetic variants in IL4RA, IL6, and IL12B genes and susceptibility to hepatitis B and C virus infections among Iraqi patients

Suchergebnisse filtern